Meeting
2017 ASCO Annual Meeting
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.
Authors
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Silvia Stacchiotti , Stefano Ferrari , Andres Redondo , Emanuela Palmerini , Nadia Hindi , M. Angeles Vaz , Anna Maria Frezza , Antonio Gutierrez , Antonio Lopez-Pousa , Giovanni Grignani , Antoine Italiano , Sarah Dumont , Jean-Yves Blay , Nicolas Penel , Daniel Bernabeu , Enrique de Alava , Dominique Ranchère-Vince , Paola Collini , Josefina Cruz , Javier Martin Broto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
NCT02066285
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11062)
DOI
10.1200/JCO.2017.35.15_suppl.11062
Abstract #
11062
Poster Bd #
385
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Regorafenib (R) in advanced solitary fibrous tumor (SFT): Results from an exploratory phase II clinical study.
First Author: Silvia Stacchiotti
Poster
2016 ASCO Annual Meeting
Sunitinib (SM) in advanced extraskeletal myxoid chondrosarcoma (EMC): Updated analysis in 11 patients (pts).
First Author: Salvatore Provenzano
Poster
2015 ASCO Annual Meeting
A phase II study of axitinib in advanced carcinoid tumors: Preliminary results.
First Author: Mauro Cives
Poster
2023 ASCO Annual Meeting
Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).
First Author: Silvia Stacchiotti